Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.
Iris LodewijkSandra P NunesRui HenriqueCarmen JerónimoMarta DueñasJesus M ParamioPublished in: Clinical epigenetics (2021)
Thus, modulating epigenetics in combination with immunotherapy might be a promising therapeutic option to improve the success of this therapy. Further studies are necessary to (1) understand in depth the impact of the epigenetic machinery in the tumor microenvironment; (2) how the epigenetic machinery can be modulated according to tumor type to increase response to immunotherapy and (3) find reliable biomarkers for a better selection of patients eligible to immunotherapy.